Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia - TCD with Transfusions Changing to Hydroxyurea (TWiTCH): A multicentre, open-label, phase 3, non-inferiority trial

Russell E. Ware, Barry R. Davis, William H. Schultz, R. Clark Brown, Banu Aygun, Sharada Sarnaik, Isaac Odame, Beng Fuh, Alex George, William Owen, Lori Luchtman-Jones, Zora R. Rogers, Lee Hilliard, Cynthia Gauger, Connie Piccone, Margaret T. Lee, Janet L. Kwiatkowski, Sherron Jackson, Scott T. Miller, Carla RobertsMatthew M. Heeney, Theodosia A. Kalfa, Stephen Nelson, Hamayun Imran, Kerri Nottage, Ofelia Alvarez, Melissa Rhodes, Alexis A. Thompson, Jennifer A. Rothman, Kathleen J. Helton, Donna Roberts, Jamie Coleman, Melanie J. Bonner, Abdullah Kutlar, Niren Patel, John Wood, Linda Piller, Peng Wei, Judy Luden, Nicole A. Mortier, Susan E. Stuber, Naomi L.C. Luban, Alan R. Cohen, Sara Pressel, Robert J. Adams

Research output: Contribution to journalArticlepeer-review

302 Scopus citations

Fingerprint

Dive into the research topics of 'Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia - TCD with Transfusions Changing to Hydroxyurea (TWiTCH): A multicentre, open-label, phase 3, non-inferiority trial'. Together they form a unique fingerprint.

Nursing and Health Professions

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience